First success in the conversion of SOMNOmedics to a stock corporation
Randersacker, October 5, 2023. SOMNOmedics, a family-owned manufacturer dedicated to sleep diagnostic devices, has set its course for a secure future through initiation its conversion from a GmbH (limited liability company) into a stock corporation, the majority of which, however, remains in family ownership.
After the conversion into a stock corporation, 25% of the shares will be used to implement charitable projects in the ANNE Foundation.
To set the paths for the conversion, a strategic minority share of 15% of SOMNOmedics is acquired as of today by VIVISOL with the prospect to strengthen its strategic presence in the Home Care field. VIVISOL is part of the SOL-group, a multinational operating company both in the technical, industrial, and medicinal gases division as well as in the home care division.
For years, VIVISOL has been one of SOMNOmedics strongest partners in various European countries. With this involvement, SOMNOmedics and VIVISOL will consolidate and intensify their cooperation for the future.